Back
Supernus Pharmaceuticals, Inc. Stock Price Chart
Meet America's Newest $1B Unicorn
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Buy
56
SUPN
Supernus Pharmaceuticals, Inc.
Last Price:
$51.14
Seasonality Move:
6.72%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing slight selling pressure.
Supernus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.16 | Buy |
| 20-day SMA: | 49.89 | Buy |
| 50-day SMA: | 48.32 | Buy |
| 200-day SMA: | 40.54 | Buy |
| 8-day EMA: | 50.53 | Buy |
| 20-day EMA: | 49.73 | Buy |
| 50-day EMA: | 48.53 | Buy |
| 200-day EMA: | 42.86 | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 61.75 | Buy |
| Chaikin Money Flow: | -387832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.91 - 51.27) | Buy |
| Bollinger Bands (100): | (44.62 - 50.92) | Buy |
Supernus Pharmaceuticals, Inc. Technical Analysis
| Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 26 | 29 | 30 | 31 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Supernus Pharmaceuticals, Inc. Stock
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 51.11 while SUPN 8-day simple moving average is 50.16, which is a Buy signal.
-
The stock price of SUPN is 51.11 while Supernus Pharmaceuticals, Inc. 20-day SMA is 49.89, which makes it a Buy.
-
Supernus Pharmaceuticals, Inc. 50-day simple moving average is 48.32 while SUPN share price is 51.11, making it a Buy technically.
-
SUPN stock price is 51.11 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 40.54, creating a Buy signal.
SUPN Technical Analysis vs Fundamental Analysis
Buy
56
Supernus Pharmaceuticals, Inc. (SUPN)
is a Buy
Is Supernus Pharmaceuticals, Inc. a Buy or a Sell?
-
Supernus Pharmaceuticals, Inc. stock is rated a BuyThe current Supernus Pharmaceuticals, Inc. [SUPN] share price is $51.11. The Score for SUPN is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Supernus Pharmaceuticals, Inc. Stock Info
Market Cap:
2.9B
Price in USD:
51.11
Share Volume:
1.2M
Supernus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
57.65
52-Week Low:
29.16
Buy
56
Supernus Pharmaceuticals, Inc. (SUPN)
is a Buy
Supernus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Supernus Pharmaceuticals, Inc. stock price today?The Supernus Pharmaceuticals, Inc. stock price is 51.11 USD today.
-
Will SUPN stock go up or go down?Supernus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Supernus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Supernus Pharmaceuticals, Inc. is not overvalued.
Is Supernus Pharmaceuticals, Inc. Stock a Buy?
-
Supernus Pharmaceuticals, Inc. share price is 51.11 while SUPN 8-day exponential moving average is 50.53, which is a Buy signal.
-
The stock price of SUPN is 51.11 while Supernus Pharmaceuticals, Inc. 20-day EMA is 49.73, which makes it a Buy.
-
Supernus Pharmaceuticals, Inc. 50-day exponential moving average is 48.53 while SUPN share price is 51.11, making it a Buy technically.
-
SUPN stock price is 51.11 and Supernus Pharmaceuticals, Inc. 200-day simple moving average is 42.86, creating a Buy signal.
Fundamental Analysis of Supernus Pharmaceuticals, Inc.
Is Supernus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $1.37 per share.
Technical Analysis of Supernus Pharmaceuticals, Inc.
Should I short Supernus Pharmaceuticals, Inc. stock?
-
SUPN Moving Average Covergence Divergence (MACD) indicator is 0.87, suggesting Supernus Pharmaceuticals, Inc. is a Buy
-
Supernus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 61.75, which suggest Supernus Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Supernus Pharmaceuticals, Inc. is (46.91 - 51.27), which suggest Supernus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Supernus Pharmaceuticals, Inc. is (44.62 - 50.92), which suggest Supernus Pharmaceuticals, Inc. is a Buy
* Supernus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.